Morepen board clears $100 million investment from Switzerland-based Corinth Group

Morepen board clears $100 million investment from Switzerland-based Corinth Group Morepen Laboratories would get an investment of $32.50 million, while the remaining $67.50 million would go to promoter group companies. Morepen Laboratories will use the funds to expand the company’s RD centre and facilities to meet growing demand for active pharmaceutical ingredients.

No comments:

Post a Comment